ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 109

Clinical features of pediatric Behçet’s disease patients in Japan

Ken-ichi Yamaguchi1 and Satoshi Fujikawa2, 1Immuno-Rheumatology Center, St. Luke's International Hospital, Tokyo, Japan, 2Immuno-Rheumatology Center, St.luke's International Hospital, Tokyo, Japan

Meeting: 2017 Pediatric Rheumatology Symposium

Keywords: Behcet's syndrome, diagnostic criteria and pediatric rheumatology

  • Tweet
  • Email
  • Print
Session Information

Date: Thursday, May 18, 2017

Title: Clinical and Therapeutic Poster Session

Session Type: Abstract Submissions

Session Time: 5:30PM-7:00PM

Background/Purpose: To diagnose pediatric patients as Behçet’s disease (BD) is challenging. Sensitivity of four BD criteria, three BD criteria made for adult patients and Paediatric Behçet’s Disease study (PEDBD) criteria1, are not high enough for Japanese pediatric BD patients (51%, 60%, 70%, 47%). The aim of this study is to clarify differences in clinical characteristics between Japanese pediatric BD patients (JP) and Japanese adult BD patients (JA) or pediatric BD patients in other countries (OP)1.

Methods: We identified 51 cases of Japanese pediatric BD by questionnaire survey of pediatric rheumatologists in Japan. Then we compared their symptoms recognized at any time during disease course with those of other two groups.

Results: Oral ulcers were found with high frequency in all groups (JP 98%, JA 96%, OP 98%). Gastrointestinal symptom were higher in both pediatric groups (JP 45%, OP 40%) than adult group (JA 23%). In many of organ involvement, frequency of JP group were lower than other groups, Ocular (JP 24%, OP 33%, JA 61%), Central Nerve System (6%, 46%, 10%), Vascular (4%, 15%, 12%) respectively.

Conclusion: There may be differences in clinical features of BD due to onset of age or residential area. These differences could be a reason for difficulty to diagnose pediatric BD patient.

References

1. Isabelle Kone-Paut et. al.:Consensus classification criteria for paediatric Behcet’s disease from prospective observational cohort PEDBD. Ann Rheum Dis 2016;75:958-64


Disclosure: K. I. Yamaguchi, None; S. Fujikawa, None.

To cite this abstract in AMA style:

Yamaguchi KI, Fujikawa S. Clinical features of pediatric Behçet’s disease patients in Japan [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 4). https://acrabstracts.org/abstract/clinical-features-of-pediatric-behcets-disease-patients-in-japan/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-features-of-pediatric-behcets-disease-patients-in-japan/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology